DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Joan Miller
Joan Miller
This Is a Program Where Learning Is Valued and the Educational Experience Is Tangible
Aptinyx Inc
Interferon May Offer First Drug Therapy for Diabetic Retinopathy
Mass. Eye and Ear and Schepens Eye Research Institute Unite Forces
New VEGF Antagonists in AMD – New Quandaries Abound
779Th Meeting of the New England Ophthalmological Society
Angiogenesis
Judah Folkman 1933–2008
The Vision of One Special Patient
Image of the Month the Human Choroid, Reconstructed in 3D
Massachusetts Eye and Ear Infirmary Quality and Outcomes 2012
Department of Ophthalmology Quality and Outcomes
VEGF: from Discovery to Therapy: the Champalimaud Award Lecture
Research & Discovery
Macugen (Pegaptanib Sodium)
HMS and Mass. Eye and Ear Ophthalmology Broadens Funding
The American Ophthalmological Society 2018
OVERVIEW: Drusolv Therapeutics Is a Clinical-Stage Drug Company Based in Philadelphia
Top View
Return of Organization Exempt from Income
Temporal Trends in the Treatment of Proliferative Diabetic Retinopathy: an AAO IRIS Registry Analysis
Vascular Endothelial Growth Factor and Age-Related Macular Degeneration: from Basic Science to Therapy
Upfront IL-18 Stakes Claim As an AMD Therapy in Practice Strategies For
45226 MEEI.Indd
VEGF and Intraocular Neovascularization: from Discovery to Therapy
Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk, and Gene-Environment Interactions – the Weisenfeld Award Lecture
2018 Issue #3
Previous Recipients of the Dean's Award
Age-Related Macular Degeneration and the Other Double Helix the Cogan Lecture
VEGF: from Discovery to Therapy: the Champalimaud Award Lecture
United States Court of Appeals for the First Circuit
2014 Ophthalmologist Power List
EYE WITNESS NEWS from HARVARD OPHTHALMOLOGY | Issue 37 • March 2019
Retina Times Supplement Celebrates the 10Th Anniversary of Women In
The Good, the Bad, and the Ugly Highlights from the 2010
Correspondence